These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX? van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548 [TBL] [Abstract][Full Text] [Related]
23. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma. Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049 [TBL] [Abstract][Full Text] [Related]
24. Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma. Helbig D Front Oncol; 2022; 12():873771. PubMed ID: 35494063 [TBL] [Abstract][Full Text] [Related]
25. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets. Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378 [TBL] [Abstract][Full Text] [Related]
26. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660 [TBL] [Abstract][Full Text] [Related]
27. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal. Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897 [TBL] [Abstract][Full Text] [Related]
28. Procollagen 1 expression in atypical fibroxanthoma and other tumors. Jensen K; Wilkinson B; Wines N; Kossard S J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286 [TBL] [Abstract][Full Text] [Related]
29. The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma. Crisan D; Schneider LA; Scharffetter-Kochanek K; Bernhard L; Crisan M; Wortsman X J Ultrasound Med; 2024 Aug; 43(8):1563-1572. PubMed ID: 38703399 [TBL] [Abstract][Full Text] [Related]
30. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients. Ørholt M; Abebe K; Rasmussen LE; Aaberg FL; Lindskov LJ; Schmidt G; Wagenblast AL; Petersen MM; Loya AC; Daugaard S; Herly M; Jensen DH; Vester-Glowinski P J Am Acad Dermatol; 2023 Dec; 89(6):1177-1184. PubMed ID: 37634740 [TBL] [Abstract][Full Text] [Related]
31. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma. Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902 [TBL] [Abstract][Full Text] [Related]
32. Fine needle aspiration cytopathology of pleomorphic dermal sarcoma. Challa BS; Plaza JA; Wakely PE Cytopathology; 2023 Sep; 34(5):472-478. PubMed ID: 37204069 [TBL] [Abstract][Full Text] [Related]
33. Rare Intravascular Involvement of Pleomorphic Dermal Sarcoma Seen During Mohs Micrographic Surgery. Carrasco Mendoza CA; Castillo JR Perm J; 2024 Dec; 28(4):95-99. PubMed ID: 39262213 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. de Feraudy S; Mar N; McCalmont TH Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147 [TBL] [Abstract][Full Text] [Related]
35. Metabolic Signature of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Expression of Hypoxia-inducible Factor-1α and Several of Its Downstream Targets. Toberer F; Winkler JK; Haenssle HA; Heinzel-Gutenbrunner M; Enk A; Hartschuh W; Helmbold P; Kutzner H; Helbig D Acta Dermatovenerol Croat; 2022 Jul; 30(1):25-31. PubMed ID: 36153716 [TBL] [Abstract][Full Text] [Related]
36. Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy. Koch M; Freundl AJ; Agaimy A; Kiesewetter F; Künzel J; Cicha I; Alexiou C Anticancer Res; 2015 Nov; 35(11):5717-35. PubMed ID: 26503993 [TBL] [Abstract][Full Text] [Related]
37. Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp. Zeller J; Kiefer J; Braig D; Winninger O; Kraus D; Hagelstein S; Eisenhardt SU Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740535 [TBL] [Abstract][Full Text] [Related]
38. Sarcoma-like tumor of head and neck skin. Nonaka D; Bishop PW Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313 [TBL] [Abstract][Full Text] [Related]
39. The incidence of atypical fibroxanthoma and pleomorphic dermal sarcoma in Denmark from 2002 to 2022. Fruergaard O; Ørholt M; Vester-Glowinski PV; Jensen DH Surg Oncol; 2024 Dec; 57():102147. PubMed ID: 39388966 [TBL] [Abstract][Full Text] [Related]